257 related articles for article (PubMed ID: 32771940)
1. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.
Janssens E; van Meerbeeck JP; Lamote K
Crit Rev Oncol Hematol; 2020 Sep; 153():103037. PubMed ID: 32771940
[TBL] [Abstract][Full Text] [Related]
2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
3. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
4. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
Hua Q; Zhu Y; Liu H
Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
[TBL] [Abstract][Full Text] [Related]
5. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
6. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
7. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
[TBL] [Abstract][Full Text] [Related]
8. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
9. Utility of volatile organic compounds as a diagnostic tool in preterm infants.
Wright H; Bannaga AS; Iriarte R; Mahmoud M; Arasaradnam RP
Pediatr Res; 2021 Jan; 89(2):263-268. PubMed ID: 32120380
[TBL] [Abstract][Full Text] [Related]
10. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
11. Assessment, origin, and implementation of breath volatile cancer markers.
Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
[TBL] [Abstract][Full Text] [Related]
12. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
13. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
14. [Determination of volatile organic compounds in lung cancer cell lines and lung cancer tissue].
Hu YJ; Qiu YH; Chen EG; Ying KJ; Yu J; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):278-84. PubMed ID: 20544990
[TBL] [Abstract][Full Text] [Related]
15. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs.
Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ
ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832
[TBL] [Abstract][Full Text] [Related]
16. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
[TBL] [Abstract][Full Text] [Related]
17. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
18. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
19. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
20. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
